July 19, 2015 – Very recently, the U.S. Food and Drug Administration (FDA) approved Brexpiprazole (Rexulti) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). Schizophrenia …

Brexpiprazole (Rexulti): A new drug to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder approved by the FDA Read more »